Osteoarthritis Clinical Trials

Find Osteoarthritis Clinical Trials Near You

Anatomic Versus Reverse Shoulder Arthroplasty for Primary Glenohumeral Osteoarthritis. A Randomized Prospective Study

Status: Recruiting
Location: See location...
Intervention Type: Device
Study Type: Interventional
Study Phase: Not Applicable
SUMMARY

There are no published prospective studies that compared 2-year functional outcomes of RTSA and anatomic TSA for the treatment of primary glenohumeral osteoarthritis with intact rotator cuffs and no excessive glenoid retroversion. The primary goal of our prospective randomized study is to determine whether RTSA have at least as good results as anatomic TSA (non-inferiority), in patients with glenohumeral osteoarthritis, without rotator cuff tears nor significant glenoid retroversion.

Eligibility
Participation Requirements
Sex: All
Minimum Age: 65
Maximum Age: 85
Healthy Volunteers: f
View:

• Primary glenohumeral arthritis,

• Intact rotator cuff,

• No important glenoid bone loss (cf exclusion criteria),

• Patients between 65 and 85 years old

• Informed Consent as documented by signature (Appendix Informed Consent Form).

Locations
Other Locations
Switzerland
La Tour Hospital
RECRUITING
Meyrin
Contact Information
Primary
Alexandre Lädermann, MD
alexandre.laedermann@gmail.com
+41 22 719 75 55
Time Frame
Start Date: 2020-09-01
Estimated Completion Date: 2027-05-01
Participants
Target number of participants: 296
Treatments
Active_comparator: Anatomic TSA
The control group will receive through a deltopectoral approach an anatomic total shoulder arthroplasty (TSA) for a primary glenohumeral arthritis
Experimental: RTSA
The experimental group will receive through a deltopectoral approach a reverse total shoulder arthroplasty RTSA for a primary glenohumeral arthritis
Related Therapeutic Areas
Sponsors
Leads: La Tour Hospital

This content was sourced from clinicaltrials.gov